Attempted Suicide Intervention Treatment and Prevention (SAMIT Program)
Launched by HOSPITAL UNIVERSITARI VALL D'HEBRON RESEARCH INSTITUTE · Feb 1, 2024
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
The SAMIT Program is a clinical trial aimed at understanding how individual psychological treatment can help people who have recently attempted suicide and were hospitalized after a serious attempt. The study is particularly important because suicide rates have increased during the COVID-19 pandemic, and many patients don’t receive enough psychological support after such attempts. In this trial, participants who are 16 years or older and have been hospitalized for at least 24 hours after a serious suicide attempt will be eligible. They will be randomly assigned to either receive eight sessions of individual therapy or the usual care provided in the hospital.
Participants in the therapy group can expect to meet with a therapist to talk about their feelings and experiences, which could help them cope better and reduce the risk of trying to harm themselves again. The researchers will follow up with participants at different points over the next year to see how they are doing. This study not only aims to help those directly involved but also hopes to gather important information about suicide attempts during the pandemic and the effectiveness of psychological treatments for those in need.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Older than 16 years.
- • Remaining hospitalized for 24 hours or more at HUVH and HCP after a MSSA for 24 or more (\> = 24 hours).
- • Needing specialized care units (including Intensive Care Units, Hyperbaric Camera Units, Burned Units, Semicritical Units)
- • Needing specialized surgical treatment, excluding superficial cuts
- • Needing extensive medical treatment and observation (gastric lavage, activated charcoal, observation of neurological tests or other complementary tests)
- • MSSA with high lethality methods (precipitation, hanging, firearm, stabbing) needing hospitalization for 24 or more hours, regardless of the treatment unit.
- Exclusion Criteria:
- • Patients with suicide attempts who were discharged in \<24 h
- • Patients under 16 years.
- • Patients with mild to severe cognitive impairment.
- • Lack of informed consent.
About Hospital Universitari Vall D'hebron Research Institute
The Hospital Universitari Vall d'Hebron Research Institute (VHIR) is a leading biomedical research center affiliated with Vall d'Hebron University Hospital in Barcelona, Spain. Committed to advancing healthcare through innovative research, VHIR focuses on translating scientific discoveries into clinical applications, enhancing patient care and outcomes. The institute fosters collaboration among multidisciplinary teams of researchers, clinicians, and industry partners, emphasizing excellence in translational medicine, clinical trials, and public health initiatives. With a strong emphasis on ethical standards and patient safety, VHIR is dedicated to contributing to the global body of knowledge in various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, Spain
Patients applied
Trial Officials
Maria Dolores Braquehais
Principal Investigator
VHIR
Pol Bruguera
Principal Investigator
Hospital Clínic-IDIBAPS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported